Loading
The first report of a urine test reading small RNAs from vesicles to detect prostate cancer and judge its grade.
Small non-coding RNAs from urinary exosomes of 235 participants were read on microarrays to build classifiers, which were then validated in a case-control sample of 1,436 subjects with 94 per cent sensitivity and 92 per cent specificity.
Promising, but case-control designs overstate accuracy compared with testing the people who would actually use it.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker, Prostate cancer.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker, Prostate cancer.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker, Prostate cancer.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker.
Shares Liquid RNA biopsy (cell-free, vesicle and platelet RNA), Biomarker.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/